Ku saabsan Dhakhtarka
Dr. Ahn Jin-hee wuxuu ka mid yahay dhakhtarka kansarka ugu fiican Seoul, South Korea.
- Dr. Ahn Jin-hee waxbarashada
-
- Dhaqtarka Caafimaadka: Jaamacadda Ulsan
- Master of Medicine: Jaamacadda Ulsan
- Bachelor of Medicine: Jaamacadda Hanyang
- Dr. Ahn Jin-hee khibrado xirfadeed
-
- Booqashada Cilmi baadhe ee Danafaber Cancer Institute, Harvard Medical School, USA
- Ku-xigeenka Professor ee cilmiga Oncology, UUCM AMC
- Kaaliyaha Professor ee Oncology, UUCM AMC
- Macallinka Caafimaadka ee UUCM AMC
- Isbahaysiga UUCM AMC
- Deganaanshaha UUCM AMC
- Tababbarka UUCM AMC
Hospital
Xarunta Caafimaadka Asan, Seoul, South Korea
takhasus
- Kansarka naasaha
- Lafaha & sarcoma unugyada jilicsan
- kansarka ilmo
- Kansarka siilka
- Kansarka qoorta
Nidaamyada la fuliyay
- Daaweynta kansarka naasaha
- Lafaha & daaweynta unugyada jilicsan ee sarcoma
- Daaweynta kansarka xubinta taranka dumarka
- Daaweynta kansarka siilka
- Daaweynta kansarka ugxantu
Cilmi baaris & Daabacaad
| Isku-darka Gemcitabine iyo Docetaxel ee loogu talagalay Sarcoma Cadka Sare ee jilicsan: Daraasad Dib-u-eegis Qaran ah. |
| Wajiga III, Isugeyn, Daraasad laba-indho-indho oo isbarbar dhigaysa Waxtarka, Badbaadada, iyo Immunogenicity-ka SB3 (Trastuzumab Biosimilar) iyo Tixraaca Trastuzumab ee Bukaannada Lagu Daaweeyay Neoadjuvant Therapy ee Aadanaha Epidermal Growth Factor Receptor 2-Positive |
| Daraasad Ku-meel-gaadh ah oo Fududeyn ah (18) F-Fluoroestradiol PET si loo saadaaliyo Jawaabta Cilmiga ah ee Daaweynta Neoadjuvant ee Kansarka Naasaha ee Estrogen Receptor-Rich Postmenopausal. |
| Darajada-kordhinta daraasadda ee heerka-kordhinta ee c-Met tyrosine kinase inhibitor SAR125844 ee bukaanada Aasiya ee leh burooyinka adag ee horumarsan, oo ay ku jiraan bukaanada qaba kansarka gaaska ee 'MET'. |
| Wajiga II, iskuduwaha kala duwan, tijaabada kala soocida ee eribulin iyo gemcitabine iyo paclitaxel oo lagu daray gemcitabine oo ah daaweynta ugu horeysa ee daaweynta kiimikada bukaanka qaba kansarka naasaha ee HER2. |
| Tayada nolosha ee TSU-68: Isku darka docetaxel iyo TSU-68, oo ah wakiilka antiangiogenic afka, bukaanka qaba kansarka naasaha ee metastatic horey loogu daaweeyay anthracycline. |
| Daraasad suurtagal ah oo la kala soocay oo loo yaqaan '18F-fluoroestradiol positron emission tomography' si loo saadaaliyo jawaabta cudurada ee neoadjuvant systemic therapy ee estrogen receptor-qaniga ah kansarka naasaha postmenopausal. |
| Muujinta Cytoplasmic ee kooxda dhaqdhaqaaqa sare ee B1 (HMGB1) waxay la xiriirtaa burooyinka infakshanka qanjidhada (TILs) ee kansarka naasaha. |
| Natiijooyinka muddada-dheer ee joojinta tyrosine kinase inhibitor-ka ee bukaannada qaba kansarka kelyaha ee metastatic. |
| Go'aamiyeyaasha monogenic iyo polygenic ee halista sarcoma: daraasad hidde caalami ah. |
| Jaangoynta jiilka soo socda ayaa muujinaya isbeddellada somalia ee jawaabta gaarka ah siiya everolimus. |
| Tijaabada Wajiga II ee neoadjuvant letrozole iyo lapatinib ee haweenka Asianka postmenopausal ee leh estrogen receptor (ER) iyo bini'aadamka koritaanka cuncunka epidermal factor receptor 2 (HER2) - kansarka naasaha oo la taaban karo [Neo-ALL-IN]: Iftiiminta 'TILs', ER isbadal muuqa ah kadib |
| Daaweynta Dabaysha Dabaysha Kadib Qalliinka Nabarrada Nabarrada ah ee loogu talagalay Sarcomas jilicsan oo unugyada 'Distal Extremities' |
| Daraasad waji 1 ah oo ku saabsan tallaalka heterologous-ka ah ee kobcinta-tallaalka ee ku lug leh taxanaha HER2 ee bukaanka qaba HER2-oo muujinaya kansarka naasaha. |
| Wareejinta Biomarkers Plasma ee loogu talagalay TSU-68, oo ah Wakiilka Afka Antiangiogenic, ee Bukaannada qaba Kansarka Naasaha ee Metastatic. |
| Muhiimadda Clinicopathologic ee Heterogeneity Intratumoral HER2 Gene Amplification ee HER2-Bukaanka Kansarka Naasaha ee Wanaagsan ee Lagu Daaweeyay Adjuvant Trastuzumab |
| Isbarbardhigga Nidaamyada Qiimeynta Jawaab-celinta Cudurka Dabeecadda ee Anthracycline ka dib / aan lahayn Cilmiga Neoadjuvant Chemotherapy ee Canshuur-ku-saleysan oo ka mid ah Noocyada kala duwan ee Kansarka Naasaha |
| Kooxda dhaqdhaqaaqa sare ee B1 iyo N1 (HMGB1 iyo HMGN1) waxay la xiriiraan qanjirada 'infakshanka' lymphocytes ee kansarka naasaha HER2-positive |
| Muhiimadda Saadaasha ee Lymphocytes-ka Tumor-infiltrating iyo Qaabdhismeedka Lymphoid Qaabdhismeedka HER2-Kansarka Naasaha ee Wanaagsan ee Lagu Daaweeyay Adjuvant Trastuzumab. |
| Baadhitaanka unugyada baadhitaanka biomarker ee loogu talagalay bukaannada qaba kansarka kelyaha ee metastatic ee qaata xididdada korriinka endothelial factor receptor tyrosine kinase inhibitors. |
